ENGOT, NSGO-CTU & GOG-Foundation proudly announce the ground-breaking results of ENGOT-EN6-NSGO/GOG-3031/RUBY trial. The results reveal improvement in overall ...
OSLO, Norway--(BUSINESS WIRE)--Ultimovacs ASA ("Ultimovacs", ticker ULTI), today announced its participation in the Phase II DOVACC collaboration study with the Nordic Society of Gynaecological ...
Find the latest (NSGO.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
The European Network for Gynaecological Oncological Trial (ENGOT) groups, the Nordic Society of Gynaecological Oncology – Clinical Trial Unit (NSGO-CTU) and the GOG Foundation, Inc. (GOG-F) are proud ...
Oslo, 15 December 2021: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, announced today that the first patient has been enrolled in the ...
Discover historical prices for NSGO.ST stock on Yahoo Finance. View daily, weekly or monthly formats back to when stock was issued.
Article ‘Count’ and ‘Share’ for Nordic Society of Gynaecological Oncology (NSGO) based on listed parameters only. The articles listed below published by authors from Nordic Society of Gynaecological ...
See (NSGO.ST) Environment, Social and Governance Ratings to help you in your stock buying decisions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback